Delivery Order SPE2DB20D3101-SPE2DB23FQXU2
Award Date 12/19/22
Potential Completion Date 12/20/22
Potential Value $4.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
- This federal contract award, valued at $4,649.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,421,527 units of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. This is a firm-fixed price delivery order contract with a completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $9,517.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,422,780 units of 4 mg Naloxone HCl Nasal Spray, a critical medication used to treat opioid overdoses. The contract is a Firm Fixed Price Delivery Order with a completion date of September 13, 2022. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award, valued at $3,571.71, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,641,340 units of Naloxone HCl 4 mg nasal spray, a critical medication used to treat opioid overdose. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This federal contract award, valued at $2,782.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,182,545 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This is a firm fixed-price delivery order with a completion date of June 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $5,684.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,874,751 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of April 11, 2025. It is not designated as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,135.04 firm fixed-price delivery order is for the procurement of 4,559,306 units of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award, valued at $7,744.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,861,499 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,039,734 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a Firm Fixed Price of $2,400.09 and a period of performance through January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,037.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,161,333 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a firm fixed-price pricing type and an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...